Process View
The directed movement of an organism or motile cell on, within or near its host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "movement in host environment"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.999 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.998 | ||
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.891 | ||
| ENG | endoglin | 0.889 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.829 | Human | |
| UBE2D4 | ubiquitin-conjugating enzyme E2D 4 (putative) | 0.787 | ||
| PVRL4 | poliovirus receptor-related 4 | 0.718 | ||
| IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.628 | ||
| FLNA | filamin A, alpha | 0.520 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.501 | ||
| FHL2 | four and a half LIM domains 2 | 0.452 | ||
| AXL | AXL receptor tyrosine kinase | 0.442 | ||
| TLN1 | talin 1 | 0.441 | ||
| CD63 | CD63 molecule | 0.438 | ||
| IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.415 | ||
| FN1 | fibronectin 1 | 0.415 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.367 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.361 | ||
| MED15 | mediator complex subunit 15 | 0.325 | ||
| DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 0.303 | ||
| TRIM5 | tripartite motif containing 5 | 0.276 | ||
| TRIM21 | tripartite motif containing 21 | 0.257 | Human Mouse | |
| PVRL3 | poliovirus receptor-related 3 | 0.227 | Human | |
| GCC1 | GRIP and coiled-coil domain containing 1 | 0.217 | ||
| PXN | paxillin | 0.160 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.153 | ||
| ZNF263 | zinc finger protein 263 | 0.148 | ||
| TRIM43 | tripartite motif containing 43 | 0.138 | ||
| ITGB4 | integrin, beta 4 | 0.133 | ||
| KDM6A | lysine (K)-specific demethylase 6A | 0.103 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.097 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.093 | ||
| THBS1 | thrombospondin 1 | 0.084 | ||
| TRIM26 | tripartite motif containing 26 | 0.069 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.064 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.060 | ||
| UBE2U | ubiquitin-conjugating enzyme E2U (putative) | 0.059 | ||
| RNF5 | ring finger protein 5 | 0.058 | ||
| STX7 | syntaxin 7 | 0.057 | ||
| TRIM41 | tripartite motif containing 41 | 0.057 | Human | |
| MAGEA4 | melanoma antigen family A, 4 | 0.056 | ||
| RNF126 | ring finger protein 126 | 0.047 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.046 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.046 | ||
| SP110 | SP110 nuclear body protein | 0.046 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.044 | ||
| TRIM39 | tripartite motif containing 39 | 0.042 | Human | |
| EFCAB4B | EF-hand calcium binding domain 4B | 0.040 | ||
| ITGB5 | integrin, beta 5 | 0.036 | ||
| BCR | breakpoint cluster region | 0.034 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.031 | ||
| PLSCR1 | phospholipid scramblase 1 | 0.031 | ||
| TRIM8 | tripartite motif containing 8 | 0.028 | Mouse | |
| FHL3 | four and a half LIM domains 3 | 0.028 | ||
| IRF9 | interferon regulatory factor 9 | 0.028 | ||
| PML | promyelocytic leukemia | 0.026 | ||
| DYDC1 | DPY30 domain containing 1 | 0.025 | ||
| TRIM32 | tripartite motif containing 32 | 0.025 | ||
| LRSAM1 | leucine rich repeat and sterile alpha motif containing 1 | 0.024 | ||
| TRIM34 | tripartite motif containing 34 | 0.024 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.024 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.024 | ||
| TRIM52 | tripartite motif containing 52 | 0.024 | ||
| STX8 | syntaxin 8 | 0.022 | ||
| ZNF473 | zinc finger protein 473 | 0.022 | ||
| SP100 | SP100 nuclear antigen | 0.022 | ||
| CTGF | connective tissue growth factor | 0.021 | ||
| UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.021 | ||
| FUT6 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | 0.021 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.021 | ||
| EPHA2 | EPH receptor A2 | 0.021 | ||
| ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 0.020 | ||
| EPHB3 | EPH receptor B3 | 0.020 | ||
| DAXX | death-domain associated protein | 0.020 | ||
| UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.019 | ||
| RNF10 | ring finger protein 10 | 0.019 | ||
| SH3BGRL | SH3 domain binding glutamic acid-rich protein like | 0.018 | ||
| BST2 | bone marrow stromal cell antigen 2 | 0.018 | ||
| MKRN3 | makorin ring finger protein 3 | 0.018 | ||
| ANXA1 | annexin A1 | 0.018 | ||
| ABHD16A | abhydrolase domain containing 16A | 0.018 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.018 | ||
| EPHB2 | EPH receptor B2 | 0.017 | ||
| PDLIM5 | PDZ and LIM domain 5 | 0.017 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.017 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.016 | Human | |
| GOLGA2 | golgin A2 | 0.016 | ||
| IFNA16 | interferon, alpha 16 | 0.015 | Human | |
| STX4 | syntaxin 4 | 0.015 | ||
| ZC3HAV1 | zinc finger CCCH-type, antiviral 1 | 0.015 | ||
| C19orf66 | chromosome 19 open reading frame 66 | 0.015 | ||
| IFNA10 | interferon, alpha 10 | 0.015 | Human | |
| GJB3 | gap junction protein, beta 3, 31kDa | 0.015 | ||
| RNF185 | ring finger protein 185 | 0.014 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.014 | ||
| MRAS | muscle RAS oncogene homolog | 0.014 | ||
| SREBF1 | sterol regulatory element binding transcription factor 1 | 0.014 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.014 | ||
| ST14 | suppression of tumorigenicity 14 (colon carcinoma) | 0.014 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.013 | ||
| IFNA4 | interferon, alpha 4 | 0.012 | ||
| CRP | C-reactive protein, pentraxin-related | 0.012 | Human | |
| TRIM35 | tripartite motif containing 35 | 0.012 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.012 | Human | |
| SHISA5 | shisa homolog 5 (Xenopus laevis) | 0.012 | ||
| PHF11 | PHD finger protein 11 | 0.012 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.012 | ||
| RNF41 | ring finger protein 41 | 0.012 | ||
| CD9 | CD9 molecule | 0.012 | ||
| USP4 | ubiquitin specific peptidase 4 (proto-oncogene) | 0.012 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.011 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.011 | ||
| RNF32 | ring finger protein 32 | 0.011 | ||
| FXYD3 | FXYD domain containing ion transport regulator 3 | 0.011 | ||
| TSGA10 | testis specific, 10 | 0.011 | ||
| VCL | vinculin | 0.011 | ||
| VTI1B | vesicle transport through interaction with t-SNAREs homolog 1B (yeast) | 0.011 | ||
| IFNA17 | interferon, alpha 17 | 0.011 | ||
| MAGEA1 | melanoma antigen family A, 1 (directs expression of antigen MZ2-E) | 0.011 | ||
| APCS | amyloid P component, serum | 0.011 | ||
| ILK | integrin-linked kinase | 0.010 | ||
| LAD1 | ladinin 1 | 0.010 | ||
| FBF1 | Fas (TNFRSF6) binding factor 1 | 0.010 | ||
| SPINT1 | serine peptidase inhibitor, Kunitz type 1 | 0.010 | ||
| MCOLN1 | mucolipin 1 | 0.010 | ||
| EPHA7 | EPH receptor A7 | 0.010 | ||
| LY6E | lymphocyte antigen 6 complex, locus E | 0.010 |